Close Menu

inflammation

The project will include the development of mass spec tools for studying systems-level protein-protein interactions.

Anagnostics aims to include the marker in a new version of its Hybcell Inflammation integrated sepsis monitoring test.

The five new grants, part of the Genomics of Gene Regulation program, will fund research into the mechanisms controlling gene expression.

NEW YORK (GenomeWeb News) – The Forsyth Institute plans to use a $4.1 million grant from the Massachusetts Life Sciences Center (MLSC) to create a new center that will develop saliva-based molecular diagnostic tests for assessing disease risk.

NEW YORK (GenomeWeb News) – Courtagen Life Sciences today said it has submitted its first pre-investigational device exemption information package to US regulators for its automated solution for measuring C-reactive proteins in a clinical setting.

A research team led by scientists at proteomics firm Cellzome has developed a selective inhibitor to the PI3 kinase isoform PI3Kγ.

SuperNova and KSB plan to develop and commercialize tests and services in China for the measurement of the analyte neopterin.

Researchers from the Novartis Institutes for BioMedical Research have identified variants in the major histocompatibility complex class II region that are associated with drug-induced liver injury related to the company's anti-inflammatory drug lumiracoxib.

The company has added respiratory and inflammation to an RNAi screening program that began with oncology.

The technology, called glucan-encapsulated siRNA particles, or GERPs, has been exclusively licensed by RXi Pharmaceuticals for use in developing RNAi-based therapeutics.

Pages

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.